魏輝，1973年生，籍貫遼寧，中國(guó)醫(yī)學(xué)科學(xué)院血液病醫(yī)院主任醫(yī)師，博士生導(dǎo)師。1993年考入中國(guó)醫(yī)科大學(xué)七年制專業(yè)，2000年獲得碩士學(xué)位。2003年在中國(guó)協(xié)和醫(yī)科大學(xué)內(nèi)科學(xué)專業(yè)攻讀博士學(xué)位，從事白血病的臨床和基礎(chǔ)研究。2010年進(jìn)入美國(guó)國(guó)立衛(wèi)生研究院做為訪問(wèn)學(xué)者從事白血病的耐藥機(jī)制的研究工作。

從事白血病的臨床和基礎(chǔ)研究工作；對(duì)急性髓系白血病的發(fā)病及耐藥機(jī)制進(jìn)行研究，基于分子機(jī)制，開(kāi)展靶向治療策略研究；通過(guò)開(kāi)展臨床試驗(yàn)、建立臨床隊(duì)列完善優(yōu)化急性白血病的診療體系。

午夜92福利1000,午夜92福利1000,久久国产亚洲高清观看5388,美女不拍网站免费观看,欧美***天天久久综合精品,中文字幕日韩系列中文字幕,综合久久国产九一剧情麻豆,丰满人妻在线免费视频,奶子大逼又嫩操起来真爽

1. Wei H#, Zhou C, Liu B, Lin D, Li Y, Wei S, Gong B, Zhang G, Liu K, Gong X, Fang Q, Liu Y, Qiu S, Gu R, Song Z, Chen J, Yang M, Zhang J, Jin J, Wang Y, Mi Y, Wang J*. The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm). Br J Haematol. 2022 May;197(4):442-451. (IF=5.908)

2. Wei H#, Wang Y#, Gale RP, Lin D, Zhou C, Liu B, Qiu S, Gu R, Li Y, Zhao X, Wei S, Gong B, Liu K, Gong X, Liu Y, Zhang G, Song Z, Wang Y, Li W, Mi Y*, Wang J*. Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia. Clin Cancer Res. 2020;26(13):3154-3161. (IF=9.937)

3. Wei H#, Zhou C, Lin D, Liu B, Li Y, Zhao X, Wei S, Gong B, Liu K, Gong X, Liu Y, Zhang G, Chen J, Zhang J, Jin J, Qiu S, Gu R, Wang Y, Mi Y, Wang J*. Benefit of intermediate-dose cytarabine containing induction in molecular subgroups of acute myeloid leukemia. Haematologica. 2020; 106(5):1491-1495. (IF=7.116)

4. Yan D#, Wei H#, Lai X, Ge Y, Xu S, Meng J, Wen T, Liu J, Zhang W*, Wang J*, Xu H*. Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia. J Control Release. 2020; 327:766-778. (IF=7.835)

5. Wei H#, Wang Y, Zhou C, Lin D, Liu B, Liu K, Qiu S, Gong B, Li Y, Zhang G, Wei S, Gong X, Liu Y, Zhao X, Gu R, Mi Y, Wang J*. Distinct genetic alterationprofiles of acute myeloid leukemia between Caucasian and Eastern Asianpopulation. J Hematol Oncol. 2018; 11(1):18. (IF=6.649)

6. Wei H#, Xiang L, Wayne AS, Chertov O, FitzGerald DJ, Bera TK, Pastan I*. Immunotoxin resistance via reversible methylation of the DPH4 promoter is a unique survival strategy. Proc Natl Acad Sci U S A. 2012; 109(18):6898-6903. (IF=9.628, F1000)

7. Wei H#,Bera TK, Wayne AS, Xiang L, Colantonio S, Chertov O, Pastan I*. A modified form ofdiphthamidecausesimmunotoxinresistance in a lymphomacelllinewith a deletionofthe WDR85 gene. J Biol Chem. 2013; 288(17): 12305-12312 (IF=4.971)